Syros Pharmaceuticals, Inc. – Securities Investigation – SYRS

Investors of Syros Pharmaceuticals Encouraged to Contact Kehoe Law Firm, P.C. – SYRS

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Syros Pharmaceuticals, Inc. (“Syros” or the “Company”) (NASDAQ: SYRS).

INVESTORS OF SYROS PHARMACEUTICALS STOCK WITH FINANCIAL LOSSES CAN CLICK HERE OR EMAIL [email protected] TO CONTACT KEHOE LAW FIRM, P.C. TO DISCUSS THE SYROS SECURITIES CLASS ACTION INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

After the market closed on November 12, 2024, Syros announced that “[o]n November 12, 2024, an event of default occurred under the Loan and Security Agreement dated February 12, 2020 . . . between Syros Pharmaceuticals, Inc. . . . and Oxford Finance LLC (the “Lender”), as a result of the failure of the Company’s SELECT-MDS-1 Phase 3 trial evaluating tamibarotene in combination with azacitidine in newly diagnosed higher-risk myelodysplastic syndrome patients with RARA gene overexpression to meet its primary endpoint of complete response rate.”

On this news, the stock price of Syros was down more than 86% during intraday trading on November 13, 2024. 

SYROS INVESTORS WITH FINANCIAL LOSSES ALSO CAN CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO LEARN MORE ABOUT THE SYROS SECURITIES CLASS ACTION INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

Revance Therapeutics Securities Investigation on Behalf of RVNC Investors

Revance Investors With Financial Losses Encouraged to Contact Kehoe Law Firm, P.C. 

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Revance Therapeutics Inc. (“Revance” or the “Company”) (NASDAQ: RVNC).

INVESTORS OF REVANCE STOCK WITH FINANCIAL LOSSES CAN CLICK HERE OR EMAIL [email protected] TO CONTACT KEHOE LAW FIRM, P.C. TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

On September 23, 2024, Revance announced, among other things, that it “. . . received a notice to remedy alleged material breaches, including breaches of the maximum levels of buffer stock and required efforts to promote and sell Teoxane products, under the Company’s exclusive distribution agreement with Teoxane SA . . .  dated January 10, 2020 . . ..”

On this news, the stock of Revance dropped more than 7% closing at $5.365 per share on September 23, 2024.

REVANCE INVESTORS WITH FINANCIAL LOSSES ALSO CAN CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO LEARN MORE ABOUT THE REVANCE SECURITIES CLASS ACTION INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

Humacyte, Inc. Securities Investigation – HUMA

Investors of Humacyte Stock With Financial Losses Encouraged to Contact Kehoe Law Firm, P.C. 

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQ: HUMA).

INVESTORS OF HUMACYTE STOCK WITH FINANCIAL LOSSES CAN CLICK HERE OR EMAIL [email protected] TO CONTACT KEHOE LAW FIRM, P.C. TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

On October 17, 2024, the stock price of Humacyte dropped more than 16%, after the FDA disclosed in a Form 483 multiple violations at the Company’s Durham, North Carolina facility, including but not limited to, inadequate quality oversight and no microbial quality assurance and testing. These violations were found during inspections that took place between April 1 through April 5, 2024.

The findings by the FDA may have run counter to statements made by the Company in May 2024 that the inspections were “very successful” and raises concerns about the Company’s transparency and commitment to regulatory compliance.

HUMACYTE INVESTORS WITH FINANCIAL LOSSES ALSO CAN CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO LEARN MORE ABOUT THE HUMACYTE SECURITIES CLASS ACTION INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

Invitation Homes Inc. – Breach of Fiduciary Duties Investigation – INVH

Investors of Invitation Homes Inc. Encouraged to Contact Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is investigating whether certain officers or directors of Invitation Homes Inc. (NYSE: INVH) failed to manage Invitation Homes in an acceptable manner, in breach of their fiduciary duties to Invitation Homes and its shareholders, and whether investors of Invitation Homes stock suffered harm.

INVESTORS OF INVITATION HOMES CAN CLICK HERE OR EMAIL [email protected] TO CONTACT KEHOE LAW FIRM, P.C. TO DISCUSS THE INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

On September 24, 2024, the Federal Trade Commission (“FTC”) announced that it “. . . is taking action against Invitation Homes, the country’s largest landlord of single-family homes, for an array of unlawful actions against consumers, including deceiving renters about lease costs, charging undisclosed junk fees, failing to inspect homes before residents moved in, and unfairly withholding tenants’ security deposits when they moved out.”

According to the FTC, “Invitation Homes has agreed to a proposed settlement order that would require the company to turn over $48 million to be used to refund consumers harmed by its actions. The corporate landlord will also be required to clearly disclose its leasing prices, establish policies and procedures to handle security deposit refunds fairly, and stop other unlawful behavior.”

SHAREHOLDERS OF INVITATION HOMES SECURITIES ALSO CAN CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO LEARN MORE ABOUT THE BREACH OF FIDUCIARY DUTIES INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

Marathon Oil Corporation – Breach of Fiduciary Duties Investigation – MRO

Investors of Marathon Oil Encouraged to Contact Kehoe Law Firm, P.C. – MRO

Kehoe Law Firm, P.C. is investigating whether certain officers or directors of Marathon Oil Corporation (“Marathon Oil”) (NYSE: MRO) failed to manage Marathon Oil in an acceptable manner, in breach of their fiduciary duties to Marathon Oil and its shareholders, and whether investors of Marathon Oil stock suffered harm.

MARATHON OIL SHAREHOLDERS CAN CLICK HERE OR EMAIL [email protected] TO CONTACT KEHOE LAW FIRM, P.C. TO DISCUSS THE INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

On July 11, 2024, the U.S. Department of Justice (“DOJ”) announced a $241.5 million settlement with Marathon Oil resolving allegations that Marathon Oil violated the Clean Air Act regarding the company’s oil and gas production operations on the Fort Berthold Indian Reservation in North Dakota.

According to the DOJ, “[t]he settlement requires that Marathon pay a civil penalty of $64.5 million, the largest ever for violations of the Clean Air Act at stationary sources, which include facilities such as oil and gas tank systems.”

According to the DOJ, “[t]he agreement requires Marathon to invest in extensive compliance measures estimated to cost $177 million, much of which will be expended by the end of 2024. The settlement requires Marathon to obtain permits with federally enforceable emissions limits at production facilities on the Fort Berthold Indian Reservation and future operations in the state of North Dakota. Compliance measures also include flare monitoring, periodic infrared camera inspections and implementation of storage tank design requirements.”

The requirements, according to the DOJ, “. . . will significantly reduce harmful health-related emissions from 169 existing facilities on state land and on the Fort Berthold Indian Reservation, as well as at new facilities built in North Dakota. Therefore, the United States will secure pollution limits on twice the number of facilities where it investigated and alleged violations.”

INVESTORS OF MARATHON OIL ALSO CAN CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO LEARN MORE ABOUT THE BREACH OF FIDUCIARY DUTIES INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

Delta Airlines – Breach of Fiduciary Duties Investigation – DAL

Investors of Delta Airlines Stock Encouraged to Contact Kehoe Law Firm, P.C. – DAL

Kehoe Law Firm, P.C. is investigating whether certain officers or directors of Delta Airlines, Inc. (“Delta” or “Delta Airlines”) (NYSE: DAL) failed to manage Delta Airlines in an acceptable manner, in breach of their fiduciary duties to Delta and its shareholders, and whether Delta Airlines and its shareholders suffered harm.

INVESTORS OF DELTA AIRLINES STOCK CAN CLICK HERE OR EMAIL [email protected] TO CONTACT KEHOE LAW FIRM, P.C. TO DISCUSS THE INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

On July 23, 2024, Axios.com reported that “[t]he U.S. Department of Transportation ‘has opened an investigation into Delta Air Lines to ensure the airline is following the law and taking care of its passengers during continued widespread disruptions,’ Transportation Secretary Pete Buttigieg wrote on X . . ..”

On July 24, 2024, CNN.com reported that “. . . Delta Air Lines canceled hundreds more flights early Tuesday morning [July 23, 2024], as the problems caused by last week’s global tech outage continued into a fifth day. Worse news: Delta’s meltdown will probably extend through the end of the week.”

According to CNN.com, “[t]he meltdown has ensnared an estimated half a million people, ruined holidays and travel plans and prompted a federal investigation – even as Delta flight cancellations and delays are ongoing and far outpacing issues at other carriers.”

Additionally, CNN.com reported that “[a]s of 2pm ET the Atlanta-based airline had canceled 466 flights, and Endeavor Air, its regional carrier that feeds its system under the Delta Connection brand, had canceled another 28 flights. The cancellations follow more than 1,250 flight cancellations Monday, and 4,500 flights from Friday through Sunday between Delta and Delta connection.”

INVESTORS OF DELTA AIRLINES ALSO CAN CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO LEARN MORE ABOUT THE BREACH OF FIDUCIARY DUTIES INVESTIGATION AND POTENTIAL LEGAL CLAIMS.